Latest filing published 16 Oct 2026 for Dr. Martens plc. Read the official filing
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Ije Nwokorie in Dr. Martens plc. We count 44 filings; the first trade dates from 13 January 2025 and the latest from 16 October 2026.
Purchases make up the whole of the open-market record (11 purchases, €1.0M). The amount is not disclosed for 4 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 33 share grants. In 2026 alone, the filings show 6 purchases and no sales.
A typical purchase (the median) is worth €154k. Scaled by market value, the purchases weigh a median 0.013% of market cap (sample: 4 purchases). Clusters matter here: 8 out of 9 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +9.9%. This is a record of the past, not a forecast.
Most recently, on 16 October 2026, the filings show an open-market purchase worth €172k in Dr. Martens plc. The median gap between a trade and its publication by RNS (LSE) is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations
Dr. Martens’ CEO and CFO bought 179 shares each as the brand holds guidance, while Burberry and JD Sports frame the sect...
Dr. Martens’ CEO and CFO each bought shares as footwear stays under pressure. We read the filings against Nike, Adidas a...